Actively Recruiting

Age: 18Years +
All Genders
NCT07237451

Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients

Led by Grigore T. Popa University of Medicine and Pharmacy · Updated on 2025-11-19

200

Participants Needed

1

Research Sites

155 weeks

Total Duration

On this page

Sponsors

G

Grigore T. Popa University of Medicine and Pharmacy

Lead Sponsor

D

Dr. C.I. Parhon Hospital, Iasi

Collaborating Sponsor

AI-Summary

What this Trial Is About

The main aim of this study is to holistically assess the cardiovascular and renal outcomes in HFpEF CKD patients with and without SGLT2 inhibition, with focus on the endothelial disfunction, MACE and mortality using clinical evaluation, flow mediated dilatation, carotid-femoral pulse wave velocity, intima-media thickness, echocardiographic parameters, NMR metabolomics and a series of novel biomarkers.

CONDITIONS

Official Title

Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age greater than 18 years
  • Ejection fraction greater than 40%
  • Patients with chronic kidney disease stage 3 or 4 (eGFR between 15 and 60 mL/min/1.73m2), diabetic or non-diabetic, with recommendation for SGLT2 inhibitors
  • Age, sex, and CKD stage 3 or 4 matched patients without SGLT2 inhibitor treatment
Not Eligible

You will not qualify if you...

  • eGFR less than 15 mL/min/1.73m2 or patients undergoing dialysis
  • Presence of congenital heart disease, decompensated cirrhosis, pregnancy, or active malignancies
  • History of coronary artery disease including acute coronary syndrome, angina, or significant coronary artery lesions confirmed by angiography
  • Presence of cardiac medical devices such as metallic joint prostheses, cardiac stents, or pacemakers
  • Active systemic infections that may interfere with biomarker results

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Dr. C.I. Parhon Hospital in Iasi

Iași, Romania

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here